SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-21-023069
Filing Date
2021-04-27
Accepted
2021-04-27 16:08:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea139786-defa14a_protara.htm DEFA14A 22246
2 GRAPHIC image_001.jpg GRAPHIC 229645
3 GRAPHIC image_002.jpg GRAPHIC 187594
  Complete submission text file 0001213900-21-023069.txt   598236
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36694 | Film No.: 21858983
SIC: 2836 Biological Products, (No Diagnostic Substances)